Nipocalimab developer Momenta Pharmaceuticals to be acquired by J&J

Nipocalimab developer Momenta Pharmaceuticals to be acquired by J&J

J&J acquisition of Momenta Pharmaceuticals : US healthcare giant Johnson & Johnson (J&J) has signed a $6.5 billion deal to acquire Momenta Pharmaceuticals, a biotech company based in Cambridge, Massachusetts, which is focused on developing drugs for the treatment of rare immune-mediated diseases. As per the terms of the all-cash transaction, shareholders of Momenta Pharmaceuticals […]

Hilb Group acquires Eldredge & Lumpkin Insurance Agency in Massachusetts

Hilb Group acquires Eldredge & Lumpkin Insurance Agency in Massachusetts

The Hilb Group (THG), a US middle market insurance agency, has acquired Massachusetts-based Eldredge & Lumpkin Insurance Agency (E&L) for an undisclosed price, as per the latest insurance acquisition news. The deal became effective on 1 July 2020, said The Hilb Group. Headquartered in Chatham, Eldredge & Lumpkin Insurance Agency is a full service insurance […]

Analog Devices to acquire Maxim Integrated Products for $21bn

Analog Devices to acquire Maxim Integrated Products for $21bn

Analog Devices (ADI), a US-based Semiconductor manufacturing company, has agreed to acquire Maxim Integrated Products, a manufacturer of analog and mixed-signal integrated circuits, in an all-stock deal worth about $21 billion. Based in California, Maxim Integrated Products caters to the automotive, industrial, consumer, communications, and computing markets with its integrated circuits. On the other hand, […]

BrainStorm Cell Therapeutics doses patients in NurOwn phase 3 trial in ALS

BrainStorm Cell Therapeutics doses patients in NurOwn phase 3 trial in ALS

NurOwn phase 3 trial : BrainStorm Cell Therapeutics, a US biotech company engaged in developing adult stem cell therapies for neurodegenerative diseases, has completed the dosing of all the participants in a phase 3 trial of NurOwn (MSC-NTF cells) in amyotrophic lateral sclerosis (ALS). The late-stage trial enrolled nearly 200 participants, who have been randomized […]

Novo Nordisk to acquire cardio-renal disease company Corvidia Therapeutics

Novo Nordisk to acquire cardio-renal disease company Corvidia Therapeutics

Novo Nordisk acquisition of Corvidia : Danish pharma company Novo Nordisk has agreed to acquire Corvidia Therapeutics from life sciences venture capital firm Sofinnova Partners in a deal worth up to $2.1 billion, in a move to expand its presence in cardiovascular disease. Corvidia Therapeutics, which is based in Boston, Massachusetts, was spun out from […]

Insurance brokerage Hub acquires Lashua-LaChance and Hatchett Insurance

Insurance brokerage Hub acquires Lashua-LaChance and Hatchett Insurance

Global insurance brokerage Hub International has acquired the assets of Lashua-LaChance & Poliks Insurance Agency for an undisclosed price. Based in Gardner, Massachusetts, Lashua-LaChance is an independent insurance agency that offers personal and business insurance solutions across New England. Founded in 1938, Lashua-LaChance is said to have acquired other local insurance agencies over the years. Peter […]

Manna Tree Partners invests in organic beef producer Verde Farms

Manna Tree Partners invests in organic beef producer Verde Farms

Private equity firm Manna Tree Partners has made a minority investment of $15 million in US organic beef producer Verde Farms. Based in Massachusetts,  Verde Farms is said to supply retail, club, and foodservice customers with 100% grass-fed, 100% pasture-raised, organic beef. Founded in 2005, the organic beef producer is claimed to have increased its revenue […]

B&G Foods acquires Massachusetts-based french fries manufacturer Farmwise

B&G Foods acquires Massachusetts-based french fries manufacturer Farmwise

B&G Foods, a New Jersey-based frozen foods manufacturer, has acquired french fries manufacturer Farmwise for an undisclosed price. Farmwise, which is based in Wellesley, Massachusetts, is the owner of the Veggie Fries, Veggie Tots, and Veggie Rings brands. Its french fries brands, which are vegan, Non-GMO Project verified and free of the top eight allergens […]

Epizyme gets FDA priority review for TAZVERIK in follicular lymphoma

Epizyme gets FDA priority review for TAZVERIK in follicular lymphoma

Epizyme has been granted priority review by the US Food and Drug Administration (FDA) for the use of TAZVERIK (tazemetostat) in relapsed or refractory follicular lymphoma (FL). As per the new drug application (NDA) that has been accepted by the FDA, the Massachusetts-based biopharma company is seeking the accelerated approval of the methyltransferase inhibitor for […]